Veracyte VCYT Product revenue — License fees and royalties
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept vcyt:CostOfRevenueLicenseFeesAndRoyalties.
The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veracyte's product revenue — license fees and royalties.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Veracyte's product revenue — license fees and royalties?
- Veracyte (VCYT) reported product revenue — license fees and royalties of $313K in Q1 2026.
- How has Veracyte's product revenue — license fees and royalties changed year-over-year?
- Veracyte's product revenue — license fees and royalties decreased by 3.4% year-over-year, from $324K to $313K.
- What is the long-term trend for Veracyte's product revenue — license fees and royalties?
- Over 3 years (2022 to 2025), Veracyte's product revenue — license fees and royalties has grown at a 3.5% compound annual growth rate (CAGR), from $1.09M to $1.21M.
- What does product revenue — license fees and royalties mean?
- This metric represents the costs associated with licensing intellectual property or paying royalties required to manufacture or sell products within the segment. These expenses are often tied to third-party technology or patent rights necessary for product commercialization. It provides insight into the company's reliance on external technology and the associated cost burden on product profitability.